SRF Limited

BSE:503806 Stok Raporu

Piyasa değeri: ₹776.6b

SRF Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

SRF şirketinin kazançları yıllık ortalama -2.8% oranında azalırken, Chemicals sektörünün kazançları yıllık 6.7% oranında artan oldu. Gelirler yıllık ortalama 7.5% oranında artan oldu. SRF şirketinin öz sermaye getirisi 13.1% olup, net marjı 11.6% dir.

Anahtar bilgiler

-2.82%

Kazanç büyüme oranı

-2.98%

EPS büyüme oranı

Chemicals Sektör Büyümesi17.68%
Gelir büyüme oranı7.54%
Özkaynak getirisi13.07%
Net Marj11.63%
Son Kazanç Güncellemesi31 Mar 2026

Yakın geçmiş performans güncellemeleri

Recent updates

Anlatı Güncellemesi Apr 30

503806: Future P/E Compression Will Likely Cap Upside Despite Margin Support

The analyst price target for SRF has been adjusted from ₹2,249.74 to ₹2,200.00 as analysts factor in updated assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News SRF has scheduled a board meeting on May 05, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026 (company filing).
Anlatı Güncellemesi Apr 08

503806: Fair View As Higher Margins Offset Lower Future P/E Multiple

Analysts have raised their fair value estimate for SRF slightly, from ₹2,239.45 to ₹2,249.74. This reflects updated assumptions for revenue growth, profit margins, a lower assumed discount rate, and a reduced future P/E multiple.
Anlatı Güncellemesi Mar 24

503806: Elevated P E And Margins Will Likely Restrain Future Returns

Analysts have modestly increased their fair value estimate for SRF from ₹2,218.36 to ₹2,239.45, citing updated assumptions regarding revenue growth, profit margins, the discount rate, and future P/E, which together support a slightly higher price target. What's in the News SRF's board approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
Anlatı Güncellemesi Mar 09

503806: Elevated P E And Modest Margins Will Likely Restrain Future Returns

Analysts now set their fair value estimate for SRF at ₹2,218, compared with the previous ₹2,244. This reflects updated assumptions around discount rate, revenue growth, profit margins and future P/E expectations.
Anlatı Güncellemesi Feb 23

503806: Elevated P E And Modest Margin Outlook Will Likely Pressure Returns

Analysts have slightly raised their price target on SRF to ₹2,244, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E. These changes keep their fair value view broadly unchanged in headline terms but reflect a modestly adjusted risk and earnings profile.
Anlatı Güncellemesi Feb 09

503806: Lower Margins And Rich P E Will Likely Pressure Returns

Analysts have raised their price target on SRF to ₹2,244 from ₹2,213, citing updated assumptions on the discount rate, revenue growth, profit margins and a higher future P/E multiple. What's in the News The board has approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
Anlatı Güncellemesi Jan 24

503806: New Pharma Plant And CFO Appointment Will Support Future Upside

Analysts have trimmed their price target on SRF to ₹3,155.83 from ₹3,183.00, reflecting slightly more conservative assumptions on revenue growth, profit margin and future P/E, as well as a marginally higher discount rate. What's in the News Board meeting on January 20, 2026 to review unaudited financial results for the quarter and nine months ended December 31, 2025, consider a new pharma intermediate plant project, and discuss a second interim dividend for FY 2025-26 (company filing).
Anlatı Güncellemesi Jan 10

503806: Future Capacity Expansion And CFO Transition Will Support Long Term Prospects

Analysts have kept their fair value estimate for SRF steady at ₹3,841, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that feed into the updated target. This signals broadly consistent expectations compared with prior research.
Anlatı Güncellemesi Dec 26

503806: Future Specialty Fluoropolymer Capacity Expansion May Support Long Term Profitability

Analysts have modestly raised their price target on SRF to a new level, in line with incremental improvements in projected revenue growth, profit margins, and a slightly lower future valuation multiple, signaling a cautiously stronger outlook for the stock. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025, with SRF initiating the process to identify a successor and ensure a smooth transition (Key Developments).
Anlatı Güncellemesi Dec 12

503806: Lower Discount Rate May Support Stronger Long Term Profitability

Analysts have raised their fair value estimate for SRF by approximately $191 to $3,841 per share, citing a modestly lower discount rate and slightly higher long term profit margin expectations that more than offset a small reduction in projected revenue growth. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025.
Anlatı Güncellemesi Nov 27

503806: CFO Transition And New Facility Approval Will Drive Upside Ahead

Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin. What's in the News Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025.
Anlatı Güncellemesi Nov 12

503806: Upcoming CFO Departure And Facility Decision Will Shape Outlook

Analysts have raised their price target for SRF from $3,138.07 to $3,182.93, citing updated forecasts that reflect slight adjustments in growth and profitability assumptions. What's in the News SRF Limited's Chief Financial Officer, Rahul Jain, announced he will step down from his position at the close of business on December 12, 2025.
Anlatı Güncellemesi Oct 29

New Facility And Supply Chain Moves Will Drive Balanced Opportunity Ahead

Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth. What's in the News SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025.
Anlatı Güncellemesi Oct 15

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

Analysts have increased their price target for SRF from $3,104.79 to $3,137.83, reflecting updated expectations for the company's financial outlook. What's in the News The Chemours Company and SRF Limited have signed strategic agreements to enhance the global supply chain for fluoropolymers and fluoroelastomers (Key Developments).
Anlatı Güncellemesi Sep 05

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

With no meaningful change in either the discount rate or forward P/E multiple, analysts have maintained SRF's fair value estimate at ₹3105. What's in the News SRF Limited has entered into strategic agreements with The Chemours Company to strengthen Chemours' global supply chain for fluoropolymers and fluoroelastomers, leveraging SRF's manufacturing capabilities.
User avatar
Yeni Anlatı Nov 28

Specialty Chemicals Innovations And Global Demand Empower Revenue Growth Journey

SRF's Specialty Chemicals growth and increased production should drive revenue and improve margins due to new product launches and efficiency gains.

Gelir ve Gider Dağılımı

SRF nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

BSE:503806 Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Mar 26157,86518,35211,4830
31 Dec 25154,84717,79211,5480
30 Sep 25152,63516,17611,3470
30 Jun 25150,47614,30911,1100
31 Mar 25146,93112,50810,8590
31 Dec 24139,49511,46910,5470
30 Sep 24135,11211,29310,3780
30 Jun 24132,64312,28610,1100
31 Mar 24131,38513,3579,7680
31 Dec 23133,46914,7609,4220
30 Sep 23137,63517,3349,0860
30 Jun 23143,13919,1368,7720
31 Mar 23148,70321,6238,5350
31 Dec 22146,41622,0558,4350
30 Sep 22145,17822,0028,4010
30 Jun 22136,29021,0168,2260
31 Mar 22124,33718,8898,1040
31 Dec 21114,91916,6477,5970
30 Sep 21102,92414,8347,1080
30 Jun 2195,54314,1676,6590
31 Mar 2184,00011,9836,3930
31 Dec 2076,50210,1106,0790
30 Sep 2073,54310,3225,8680
30 Jun 2069,9139,1745,6520
31 Mar 2072,0949,1595,5670
31 Dec 1978,8179,5116,0600
30 Sep 1978,4117,5925,8620
30 Jun 1971,2166,3314,9930
31 Mar 1970,9965,9164,9010
31 Dec 1872,3295,7475,3060
30 Sep 1866,6605,4025,1990
30 Jun 1860,3704,9174,7770
31 Mar 1855,8904,6175,0350
31 Dec 1753,0264,6704,9510
30 Sep 1750,3854,4424,8270
30 Jun 1748,9524,6424,4650
31 Mar 1748,2185,1504,5850
31 Dec 1645,8334,7874,4910
30 Sep 1645,4594,7094,3630
30 Jun 1645,9804,5374,0160
31 Mar 1645,9274,2994,0940
31 Dec 1545,3533,7465,7880
30 Sep 1545,5113,4535,7220
30 Jun 1545,7593,2355,7010

Kaliteli Kazançlar: 503806 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 503806 'nin mevcut net kar marjları (11.6%) geçen yılın (8.5%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 503806 şirketinin kazançları son 5 yılda yılda 2.8% oranında azaldı.

Büyüme Hızlandırma: 503806 'un son bir yıldaki kazanç büyümesi ( 46.7% ) 5 yıllık ortalamasını (yıllık -2.8% ) aşıyor.

Kazançlar vs. Sektör: 503806 geçen yılki kazanç büyümesi ( 46.7% ) Chemicals sektörünün 10.4% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: 503806 'nin Özsermaye Getirisi ( 13.1% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/21 08:19
Gün Sonu Hisse Fiyatı2026/05/21 00:00
Kazançlar2026/03/31
Yıllık Kazançlar2026/03/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

SRF Limited 42 Bu analistlerden 31, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
null null360 ONE Capital Market Private Limited
Kumar Saumya SinghAmbit Capital
Nitin BhasinAmbit Capital